Works matching AU Belmont, Lisa D.

Results: 5
    1

    Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 279, p. 1, doi. 10.1126/scitranslmed.aaa4642
    By:
    • Leverson, Joel D.;
    • Phillips, Darren C.;
    • Mitten, Michael J.;
    • Boghaert, Erwin R.;
    • Diaz, Dolores;
    • Tahir, Stephen K.;
    • Belmont, Lisa D.;
    • Nimmer, Paul;
    • Yu Xiao;
    • Xiaoju Max Ma;
    • Lowes, Kym N.;
    • Kovar, Peter;
    • Jun Chen;
    • Sha Jin;
    • Smith, Morey;
    • Xue, John;
    • Haichao Zhang;
    • Oleksijew, Anatol;
    • Magoc, Terrance J.;
    • Vaidya, Kedar S.
    Publication type:
    Article
    2
    3

    Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors.

    Published in:
    PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109366
    By:
    • Wang, Weiru;
    • Elkins, Kristi;
    • Oh, Angela;
    • Ho, Yen-Ching;
    • Wu, Jiansheng;
    • Li, Hong;
    • Xiao, Yang;
    • Kwong, Mandy;
    • Coons, Mary;
    • Brillantes, Bobby;
    • Cheng, Eric;
    • Crocker, Lisa;
    • Dragovich, Peter S.;
    • Sampath, Deepak;
    • Zheng, Xiaozhang;
    • Bair, Kenneth W.;
    • O'Brien, Thomas;
    • Belmont, Lisa D.
    Publication type:
    Article
    4

    Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

    Published in:
    2011
    By:
    • Wertz, Ingrid E.;
    • Kusam, Saritha;
    • Lam, Cynthia;
    • Okamoto, Toru;
    • Sandoval, Wendy;
    • Anderson, Daniel J.;
    • Helgason, Elizabeth;
    • Ernst, James A.;
    • Eby, Mike;
    • Liu, Jinfeng;
    • Belmont, Lisa D.;
    • Kaminker, Joshua S.;
    • O'Rourke, Karen M.;
    • Pujara, Kanan;
    • Kohli, Pawan Bir;
    • Johnson, Adam R.;
    • Chiu, Mark L.;
    • Lill, Jennie R.;
    • Jackson, Peter K.;
    • Fairbrother, Wayne J.
    Publication type:
    Correction Notice
    5

    Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

    Published in:
    Nature, 2011, v. 471, n. 7336, p. 110, doi. 10.1038/nature09779
    By:
    • Wertz, Ingrid E.;
    • Kusam, Saritha;
    • Lam, Cynthia;
    • Okamoto, Toru;
    • Sandoval, Wendy;
    • Anderson, Daniel J.;
    • Helgason, Elizabeth;
    • Ernst, James A.;
    • Eby, Mike;
    • Jinfeng Liu;
    • Belmont, Lisa D.;
    • Kaminker, Josh S.;
    • O'Rourke, Karen M.;
    • Pujara, Kanan;
    • Kohli, Pawan Bir;
    • Johnson, Adam R.;
    • Chiu, Mark L.;
    • Lill, Jennie R.;
    • Jackson, Peter K.;
    • Fairbrother, Wayne J.
    Publication type:
    Article